Perella Weinberg Partners Capital Management LP purchased a new stake in shares of iShares MBS ETF (NASDAQ:MBB – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 2,775 shares of the company’s stock, valued at approximately $261,000. iShares […]
HC Wainwright reiterated their buy rating on shares of Cartesian Therapeutics (NASDAQ:RNAC – Free Report) in a research note issued to investors on Thursday morning, Benzinga reports. HC Wainwright currently has a $54.00 price objective on the stock. Several other analysts also recently weighed in on the company. Needham & Company LLC restated a buy […]
HC Wainwright restated their buy rating on shares of Cartesian Therapeutics (NASDAQ:RNAC – Free Report) in a report published on Thursday morning, Benzinga reports. HC Wainwright currently has a $54.00 price objective on the stock. Other equities research analysts also recently issued reports about the stock. SVB Leerink assumed coverage on shares of Cartesian Therapeutics […]
Advisory Services Network LLC reduced its stake in iShares MBS ETF (NASDAQ:MBB – Free Report) by 25.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 43,962 shares of the company’s stock after selling 14,989 shares during the period. Advisory Services […]
Founders Financial Alliance LLC reduced its stake in iShares MBS ETF (NASDAQ:MBB – Free Report) by 8.9% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,348 shares of the company’s stock after selling 132 shares during the period. Founders Financial Alliance LLC’s holdings […]